DexCom Files 8-K Amendment on Officer/Director Changes

Ticker: DXCM · Form: 8-K/A · Filed: May 9, 2025 · CIK: 1093557

Dexcom INC 8-K/A Filing Summary
FieldDetail
CompanyDexcom INC (DXCM)
Form Type8-K/A
Filed DateMay 9, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: officer-changes, director-changes, amendment

Related Tickers: DXCM

TL;DR

DexCom filed an 8-K amendment regarding leadership changes. Keep an eye on who's in and out.

AI Summary

DexCom, Inc. filed an amendment (8-K/A) on May 9, 2025, to its report originally dated March 6, 2025. The amendment pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Specific details regarding these changes were not provided in the excerpt.

Why It Matters

This filing indicates potential shifts in the leadership or compensation structure of DexCom, which could impact the company's strategic direction and governance.

Risk Assessment

Risk Level: medium — Amendments to 8-K filings concerning officer and director changes can signal internal shifts that may affect company strategy or stability.

Key Players & Entities

FAQ

What specific officer or director changes are detailed in this 8-K/A filing?

The provided text indicates the filing is an amendment related to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements, but does not specify the individuals or exact changes.

What was the original report date for this filing?

The original report date was March 6, 2025.

When was this amendment (8-K/A) filed?

This amendment was filed on May 9, 2025.

What is the principal executive office address for DexCom, Inc.?

The principal executive office address is 6340 Sequence Drive, San Diego, CA 92121.

What is DexCom, Inc.'s telephone number?

DexCom, Inc.'s telephone number is (858) 200-0200.

Filing Details

This Form 8-K/A (Form 8-K/A) was filed with the SEC on May 9, 2025 regarding DEXCOM INC (DXCM).

View full filing on EDGAR

View Full Filing

View this 8-K/A filing on SEC EDGAR

View on Read The Filing